Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Anesteziol Reanimatol ; (2): 30-4, 2013.
Article in Russian | MEDLINE | ID: mdl-24000648

ABSTRACT

Recently, the number of liver resection has increased, which requires adequate and safe anesthesia provision in this surgery area. Cytokine plasma spectrum is the one of the most important indicators characterizing inflammatory reaction intensity during and after surgery and postoperative period flow prognosis. Immune monitoring gives a notion about operative rauma features, liver damage severity, anaesthesia adequacy. Interleukin dynamics evaluation during liver resections is a topical theoretical and practical problem. The aim of this research was to evaluate the interleukins intraoperative dynamics in liver resection patients. Anaesthesia protocols were analyzed in 51 patients, 26 (51%) of which was a Sevorane multi-component balanced anaesthesia, and 25 (49%) - Propofol multi-component balanced anaesthesia. Intraoperative haemodynamics, metabolism, General and biochemical blood tests, coagulogramm, C3 and C4 complement factors dynamics, cytokines data were evaluated The obtained data testified systemic inflammatory response with a marked pro - and anti-inflammatory cytokines imbalance formation development in patients underwent organ-conserving and major liver resection. Sevorane use leads to a more pronounced anti-inflammatory cytokines synthesis in comparison with TIVA-group, the imbalance of pro - and anti-inflammatory cytokines is also more pronounced in Sevorane-group.


Subject(s)
Anesthesia, General/methods , Blood Loss, Surgical , Cytokines/blood , Hepatectomy , Monitoring, Intraoperative/methods , Systemic Inflammatory Response Syndrome/immunology , Anesthesia, General/adverse effects , Biomarkers/blood , Blood Loss, Surgical/statistics & numerical data , Complement C3/analysis , Complement C4/analysis , Female , Hepatectomy/adverse effects , Hepatectomy/methods , Humans , Male , Middle Aged , Respiration, Artificial , Systemic Inflammatory Response Syndrome/blood
2.
Anesteziol Reanimatol ; (2): 63-6, 2013.
Article in Russian | MEDLINE | ID: mdl-24000655

ABSTRACT

It was studied the influence of CVVHDF start time on MODS treatment results in 51 patients after cardiac surgery. It was found that early CVVHDFstart as apart of MODS treatment reduces the SIRS severity, normalizes cytokines balance, which leads to ALV duration decrease and significant reduction in renal replacement therapy (RRT) requirements and 28-day mortality rate.


Subject(s)
Cardiac Surgical Procedures , Early Medical Intervention/methods , Hemodiafiltration/methods , Multiple Organ Failure/prevention & control , Postoperative Complications/prevention & control , Adult , Aged , Female , Hemofiltration/methods , Humans , Male , Middle Aged , Multiple Organ Failure/diagnosis , Multiple Organ Failure/etiology , Multiple Organ Failure/mortality , Postoperative Complications/etiology , Time Factors , Treatment Outcome , Young Adult
3.
Anesteziol Reanimatol ; (3): 67-71, 2012.
Article in Russian | MEDLINE | ID: mdl-22993930

ABSTRACT

The aim is to investigate the effectiveness of SIRS pharmacological correction in patients after CABG when adding clarithromycin to the standard antibacterial therapy. Patients of the 1st group (n=25) received Klacid- CP ("Abbott") in perioperative period plus to standard antibacterial therapy (3rd generation cephalosporins), patients of 2nd group received standard therapy. At 1st screening stage, as well as on the 2-nd and 4-th day after operation were recorded data of an anamnesis, concomitant pathology, examination, were measured the level of white blood cells, LII, biochemical blood analysis (CRP), defined the concentration of interleukins (IL-1, 6, 8,10,12) and TNF - a. In all studied patients, laboratory' and physical data did not go beyond the reference values, intraoperation data, blood loss and ALV duration did not statistically differ. According to the results of research in patients of both groups there were manifestations of SIRS in the form of reliable significant increase in body temperature, as well as the level of Il-6, IL-8, CRP, LII, TNF - a, leukocytosis. While in the clarithromycin group body temperature was significantly lower in all time points. The level of CRP for the 4th day in 1.5 times, and TNF in 4 times less than in the control group, and the values of anti-inflammatory IL-10 to the 2nd day, on the contrary almost in 2 times higher than those in the control group. Thus, the obtained data confirmed that the CABG is accompanied by non-inflammatory SIRS development. At the same time clarithromycin gives an independent proven anti-inflammatory effect and can be recommended for application in the schemes of prophylactic antimicrobial therapy during perioperative period in this category of patients.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Clarithromycin/therapeutic use , Myocardial Revascularization , Postoperative Complications/prevention & control , Systemic Inflammatory Response Syndrome/prevention & control , Anti-Bacterial Agents/administration & dosage , Biomarkers/blood , Clarithromycin/administration & dosage , Double-Blind Method , Drug Therapy, Combination , Female , Humans , Male , Postoperative Complications/blood , Postoperative Complications/etiology , Postoperative Complications/immunology , Prospective Studies , Severity of Illness Index , Systemic Inflammatory Response Syndrome/blood , Systemic Inflammatory Response Syndrome/etiology , Systemic Inflammatory Response Syndrome/immunology , Treatment Outcome
4.
Anesteziol Reanimatol ; (2): 38-42, 2011.
Article in Russian | MEDLINE | ID: mdl-21688658

ABSTRACT

The aim of our study was to examine the effect of individual schemes of multimodal analgesia on indicators of immunity and inflammation markers after operations on the colon. Patients of group 1 (n=15) received paracetamol, lornoxicam and epidural ropivacaine, 2nd group of patients (n=15)-paracetamol, epidural ropivacaine and tramadol. Comparison group (n=10) patients underwent patient controlled analgesia by promedol. Before surgery, 1st and 3rd days after surgery we examined the contents of cytokines in plasma: interleukin 12p70, interleukin 10, interleukin 6, and TNF. Before surgery and at 5-7 days after surgery indicators of cellular, fagocytal and humoral immunity were monitored. Before surgery patients with colorectal cancer revealed changes in the indices of different components of immunity, as well as an increase in pro-and anti-inflammatory cytokines compared with healthy donors. Multimodal analgesia in patients after operations on the colon is not accompanied by changes in plasma concentrations of cytokines and parameters of immune status in comparison with monoanalgesia by promedol.


Subject(s)
Analgesia/methods , Analgesics/therapeutic use , Cytokines/blood , Intestine, Large/surgery , Pain, Postoperative/drug therapy , Pain, Postoperative/immunology , Adult , Aged , Aged, 80 and over , Analgesia/adverse effects , Analgesia, Epidural/adverse effects , Analgesia, Epidural/methods , Analgesia, Patient-Controlled/adverse effects , Analgesia, Patient-Controlled/methods , Analgesics/administration & dosage , Analgesics/adverse effects , Colorectal Neoplasms/immunology , Colorectal Neoplasms/surgery , Humans , Immunity, Cellular/drug effects , Immunity, Humoral/drug effects , Middle Aged , Pain, Postoperative/blood , Treatment Outcome
5.
Anesteziol Reanimatol ; (5): 79-83, 2004.
Article in Russian | MEDLINE | ID: mdl-15573734

ABSTRACT

The results of monitoring of immune parameters in different categories of surgical patients with postoperative purulent-inflammatory complications are described in the paper. The combined type of secondary immunodeficiency and degree second immunodeficiency according to A.M. Zemskov were detected in all patients. Immunocorrecting drugs, like polyoxidonium, imunofan and likopid, were added to the complex treatment of patients with the above complications. Their administration normalized the dynamic clinical course of the purulent-inflammatory processes and restored the immunological parameters.


Subject(s)
Adjuvants, Immunologic/therapeutic use , Inflammation/drug therapy , Postoperative Complications/drug therapy , Suppuration/drug therapy , Adjuvants, Immunologic/administration & dosage , Adult , Aged , Antibody Formation/drug effects , Biomarkers/analysis , Female , Humans , Immunity, Cellular/drug effects , Inflammation/immunology , Male , Middle Aged , Phagocytosis/drug effects , Postoperative Complications/immunology , Postoperative Period , Suppuration/immunology
6.
Anesteziol Reanimatol ; (5): 46-9, 2000.
Article in Russian | MEDLINE | ID: mdl-11220936

ABSTRACT

Eighty-five patients with acquired heart diseases with and without infective endocarditis (IE) were examined. In one group of patients traditional therapy was supplemented by the Russian drug immunofan, a synthetic hexapeptide with immunomodulating, antiinflammatory, and detoxifying effects. A course consisted of 10 intramuscular injections every other day (1 ml of 0.005% solution). The drug was prescribed after immunological studies on a laser flow cytometer (Becton Dickinson, USA). Correction was carried out before and after the operation. The postoperative period was uneventful in patients treated with immunofan; the incidence of clinical manifestations of IE was decreased. The concentrations of cytokines (IL-1, IL-6, TNF-alpha) in the blood were increased in patients with IE. In patients treated with immunofan, the concentrations of cytokines were decreased and immune parameters were normalized. Changes in the cytokine status can be used as a laboratory test for evaluating the efficiency of treatment in cardiosurgical patients with IE.


Subject(s)
Adjuvants, Immunologic/therapeutic use , Endocarditis, Bacterial/prevention & control , Heart Valve Diseases/surgery , Oligopeptides/therapeutic use , Postoperative Complications/prevention & control , Adjuvants, Immunologic/administration & dosage , Adult , Antigens, CD/immunology , B-Lymphocytes/immunology , Cytokines/blood , Endocarditis, Bacterial/immunology , Extracorporeal Circulation , Female , Humans , Immunoglobulins/immunology , Injections, Intramuscular , Killer Cells, Natural/immunology , Male , Oligopeptides/administration & dosage , Postoperative Complications/immunology , T-Lymphocytes/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...